MedPath

Correlation of preoperative combined positron emission tomography/computed tomograpy with surgical and histopathological findings for patients with endometrial cancer

Not Applicable
Conditions
Endometrial (Uterine) cancer
Cancer - Womb (Uterine or endometrial cancer)
Registration Number
ACTRN12609000402246
Lead Sponsor
Southern Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

All women presenting to Southern Health with diagnosis of endometrial cancer

Exclusion Criteria

Previous surgery for endometrial cancer
other cancers
Not for surgical intervention

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evidence of fluoro-2-deoxyglucose (FDG) uptake corresponding with presence of primary lesion<br>Will Use regression techniques to examine the influence of prognostic variables on test characteristics. For each of the tests calculate sensitivity, specificity, positive and negative values and compare the performance of the two tests with risk ratios and 95% confidence intervals[Following surgery and review of histopathology: Baseline only];Evidence of FDG uptake corresponding with presence of distant disease including lymphatic spread<br>Will Use regression techniques to examine the influence of prognostic variables on test characteristics. For each of the tests calculate sensitivity, specificity, positive and negative values and compare the performance of the two tests with risk ratios and 95% confidence intervals[Following surgery and review of histopathology: Baseline only]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath